From the gene to antibody
DNA immunization permits in vivo antigen production by avoiding all protein production steps and offer better results with hydrophobic proteins. The antigen is displayed on its natural conformation with all post translational modifications and the quality is
significantly improved compared to bacterial or yeast production. The DNA immunization is a powerful alternative leading decrease the project duration and increase the project chance of success to obtain a highly specific conformational antibody.
Extraction from custom plasmid or de novo synthesis from nucleic sequence.Proprietary plasmid optimized for in vivo DNA vectorization.
8 mice exclusive 63-day protocol Immunoreactivity comparison over time.
Fusion of spleen cells with myeloma cell line.
ELISA tests on growing cell hybridomas to confirm positive hybridomas stability.
Cell seeding by limiting dilution.
ELISA tests to confirm positive clones and antibody production stability.
Complete isotyping and freezing.
The first step of the development procedure consists in the plasmid preparation. The plasmid can be designed , synthetized and cloned by our services or directly sent by the customer.
The target sequences is then integrated into Covalab's proprietary vector optimized for in vivo DNA vectorization
The animals are transfected with the plasmid. The protein over-expression leads to an immune response. Test bleeds are assayed according to a detection method developed specifically for the project to adapt the protocol if necessary. In case of low immune response, additional injections and/or bleeds can be performed.
To optimise the reaction parameters and avoid adverse effects on antibody immunoreactivity, preliminary studies need to be run following adapted procedures to…
More details about our labelling services…